Similar articles for PMID: 21147758

Year	Number of Results
1986	1
1988	1
1990	1
1991	3
1995	2
1998	1
2001	1
2002	3
2003	1
2004	3
2005	4
2006	4
2007	3
2008	2
2009	1
2010	4
2011	6
2012	1
2013	8
2014	10
2015	12
2016	10
2017	6
2018	4
2019	8
2020	2
2021	1
2022	0

1

Delta inulin: a novel, immunologically active, stable packing structure comprising β-D-[2 -> 1] poly(fructo-furanosyl) α-D-glucose polymers.

Cooper PD, Petrovsky N. Cooper PD, et al. Glycobiology. 2011 May;21(5):595-606. doi: 10.1093/glycob/cwq201. Epub 2010 Dec 7. Glycobiology. 2011. PMID: 21147758 Free PMC article.

2

Gamma ray sterilization of delta inulin adjuvant particles (Advax™) makes minor, partly reversible structural changes without affecting adjuvant activity.

Cooper PD, Barclay TG, Ginic-Markovic M, Petrovsky N. Cooper PD, et al. Vaccine. 2014 Jan 23;32(5):552-7. doi: 10.1016/j.vaccine.2013.11.105. Epub 2013 Dec 14. Vaccine. 2014. PMID: 24342245 Free PMC article.

3

The polysaccharide inulin is characterized by an extensive series of periodic isoforms with varying biological actions.

Cooper PD, Barclay TG, Ginic-Markovic M, Petrovsky N. Cooper PD, et al. Glycobiology. 2013 Oct;23(10):1164-74. doi: 10.1093/glycob/cwt053. Epub 2013 Jul 12. Glycobiology. 2013. PMID: 23853206 Free PMC article.

4

Algammulin, a new vaccine adjuvant comprising gamma inulin particles containing alum: preparation and in vitro properties.

Cooper PD, Steele EJ. Cooper PD, et al. Vaccine. 1991 May;9(5):351-7. doi: 10.1016/0264-410x(91)90063-c. Vaccine. 1991. PMID: 1872020

5

Advax™, a novel microcrystalline polysaccharide particle engineered from delta inulin, provides robust adjuvant potency together with tolerability and safety.

Petrovsky N, Cooper PD. Petrovsky N, et al. Vaccine. 2015 Nov 4;33(44):5920-6. doi: 10.1016/j.vaccine.2015.09.030. Epub 2015 Sep 25. Vaccine. 2015. PMID: 26407920 Free PMC article. Review.

6

Vaccine adjuvants based on gamma inulin.

Cooper PD. Cooper PD. Pharm Biotechnol. 1995;6:559-80. doi: 10.1007/978-1-4615-1823-5_24. Pharm Biotechnol. 1995. PMID: 7551236 Review.

7

Anti-complementary action of polymorphic "solubility forms" of particulate inulin.

Cooper PD, Carter M. Cooper PD, et al. Mol Immunol. 1986 Aug;23(8):895-901. doi: 10.1016/0161-5890(86)90075-1. Mol Immunol. 1986. PMID: 3796631

8

Development of soluble inulin microparticles as a potent and safe vaccine adjuvant and delivery system.

Kumar S, Tummala H. Kumar S, et al. Mol Pharm. 2013 May 6;10(5):1845-53. doi: 10.1021/mp3006374. Epub 2013 Apr 10. Mol Pharm. 2013. PMID: 23506468

9

Investigation of the biodistribution, breakdown and excretion of delta inulin adjuvant.

Wang L, Barclay T, Song Y, Joyce P, Sakala IG, Petrovsky N, Garg S. Wang L, et al. Vaccine. 2017 Aug 3;35(34):4382-4388. doi: 10.1016/j.vaccine.2017.06.045. Epub 2017 Jul 1. Vaccine. 2017. PMID: 28676380

10

Toll-like Receptor-4 (TLR4) Agonist-Based Intranasal Nanovaccine Delivery System for Inducing Systemic and Mucosal Immunity.

Bakkari MA, Valiveti CK, Kaushik RS, Tummala H. Bakkari MA, et al. Mol Pharm. 2021 Jun 7;18(6):2233-2241. doi: 10.1021/acs.molpharmaceut.0c01256. Epub 2021 May 19. Mol Pharm. 2021. PMID: 34010002

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed